National Bank of Canada
IMNM icon

National Bank of Canada’s Immunome IMNM Stock Holding History

National Bank of Canada’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.98K Sell
182
-5
-3% -$111 ﹤0.01% 2505
2025
Q4 		$4.02K Buy
+187
New +$3.28K ﹤0.01% 2472
2024
Q4 		– Sell
-1
Closed -$15 – 3055
2024
Q3 		$15 Buy
+1
New +$14 ﹤0.01% 2667

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

National Bank of Canada's IMNM Position: Q1 2026 in Review

National Bank of Canada reduced its Immunome (IMNM) stake by 2.7% in Q1 2026, selling an estimated $111 and leaving 182 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

National Bank of Canada first reported a position in IMNM in Q3 2024 and has held it in 3 quarters since. The position peaked at $4.02K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • National Bank of Canada held 182 shares of Immunome worth $3.98K as of Q1 2026.
  • National Bank of Canada sold 5 Immunome shares in Q1 2026, an estimated $111.
  • Immunome made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2505 holding.
  • National Bank of Canada first reported a position in Immunome in Q3 2024 and has held it in 3 quarters since.
  • National Bank of Canada's Immunome position peaked at $4.02K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.